- 501-1000 Employees
- Based in Boston, Massachusetts
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first-and-only…More approved neonatal Fc receptor (FcRn) blocker in the U.S., the EU, Japan and the UK.
REPORT RATINGS4.7 / 5.0 (78)
argenx reports have an aggregate usefulness score of 4.7 based on 78 reviews.
Most Recent Responsibility Report
2021 Environmental, Social and Governance Report
Report Locked. argenx has reached its limit for free report views.
Our service enables potential investors to review the most recent and archived argenx Sustainability Report, argenx Corporate Social Responsibility Report, argenx CSR Report, argenx Corporate Responsibility, argenx CR Report, argenx Citizenship Report, argenx ESG Report, and argenx Environmental Report online.